Prevalence and Clinical Profile of Resistant Hypertension among Treated Hypertensive Subjects

REFERENCES

• Calhoun D, Jones D, Textor S. Resistant hypertension. Diagnosis, evaluation and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for Blood Pressure Research. Circulation 2008; 117:e510–e526.
   PubMed Web of Science ®Google Scholar
• Pisoni R, Ahmed M, Calhoun D. Characterization and treatment of resistant hypertension. Curr Cardiol Rep 2009; 11(6):407–413.
   PubMedGoogle Scholar
• Tobe S, Lewanczuk R. Resistant hypertension. Can J Cardiol 2009; 25(5):315–317.
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Bakris GL. Resistant hypertension: an overview of evaluation and treatment. J Am Coll Cardiol 2008; 52:1749–1757.
   PubMed Web of Science ®Google Scholar
• Cuspidi C, Macca G, Sampieri L. High prevalence of cardiac and extracardiac organ damage in refractory hypertension. J Hypertens 2001; 19:2063–2070.
   PubMed Web of Science ®Google Scholar
• Sarafidis PA, Bakris GL. State of hypertension management in the United States: confluence of risk factors and prevalence of resistant hypertension. J Clin Hypertens (Greenwich) 2008; 10:130–139.
   PubMed Web of Science ®Google Scholar
• Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903–1913.
   PubMed Web of Science ®Google Scholar
• Pierdomenico SD, Lapenna D, Bucci A. Cardiovascular outcome in treated hypertensive patients with responder, mask, false resistant and true resistant hypertension. Am J Hypertens 2005; 18:1422–1428.
   PubMed Web of Science ®Google Scholar
• Artigao LM, Llavador JJ, Puras A. Evaluation and validation of Omron Hem 705 CP and Hem 706/711 monitors for self-measurement of blood pressure. Aten Primaria 2000; 25(2):96–102.
   PubMedGoogle Scholar
• O’Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self measurement of blood pressure according to the revised British Hypertension Society Protocol: the OMRON HEM-705 CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996; 1:55–61.
   PubMedGoogle Scholar
• Persell SD. Prevalence of resistant hypertension in the United States, 2003–2008. Hypertension 2011; 57:1076–1080.
   PubMed Web of Science ®Google Scholar
• Cushman WC, Ford CE, Cutler JA. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002; 4:393–404.
   PubMedGoogle Scholar
• Lloyd-Jones DM, Evans JC, Larson MG, O’Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension 2000; 36:594–599.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Devereux RB, Kjeldsen SE, , for the LIFE Study Group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomized trial against atenolol. Lancet 2002; 359:995–1003.
   PubMed Web of Science ®Google Scholar
• Dahlöf B, Sever PS, Poulter NR. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethaizide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet 2005; 366(9489):895–906.
   PubMed Web of Science ®Google Scholar
• Lindholm LH, Carlberg B, Samuelsson O. Should beta-blockers remail first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366:1545–1553.
   PubMed Web of Science ®Google Scholar
• Wiysonge CS, Bradley H, Mayosi BM. Beta-blockers for hypertension. Cochrane Database Syst Rev 2007; 1:CD002003.
   PubMedGoogle Scholar
• Franklin SS, Gustin W IV, Wong ND. Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96(1):308–315.
   PubMed Web of Science ®Google Scholar
• Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension a meta-analysis. CMAJ 2006; 174:1737–1742.
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczac A. 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25(6):1105–1187.
   PubMed Web of Science ®Google Scholar
• Gradman AH, Basile JN, Carter BL, Bakris GL, on behalf of the American Society of Hypertension Writing Group. Combination therapy in hypertension. J Clin Hypertens 2011; 13:146–154.
   PubMed Web of Science ®Google Scholar
• National Clinical Guideline Centre (UK). Hypertension: The Clinical Management of Primary Hypertension in Adults: Update of Clinical Guidelines 18 and 34. London: Royal College of Physicians (UK), 2011. Available at: http://www.ncbi.nlm.nih.gov/books/NBK83274/ (last accessed 12 September 2012).
   Google Scholar
• Kario K, Tobin JN, Wolfson LI. Lower standing systolic blood pressure as a predictor of falls in the elderly: a community-based prospective study. J Am Coll Cardiol 2001; 38:246–252.
   PubMed Web of Science ®Google Scholar
• Heitterachi E, Lord SR, Meyerkort P, McCloskey I, Fitzpatrick R. Blood pressure changes on upright tilting predict falls in older people. Age Ageing 2002; 31:181–186.
   PubMed Web of Science ®Google Scholar
• Eigenbrodt ML, Rose KM, Couper DJ, Arnett DK, Smith R, Jones D. Orthostatic hypotension as a risk factor for stroke: the Atherosclerosis Risk in Communities (ARIC) study, 1987–1996. Stroke 2000; 31:2307–2313.
   PubMed Web of Science ®Google Scholar
• Fedorowski A, Stavenow L, Hedblad B, Berglund G, Nilsson PM, Melandr O. Orthostatic hypotension predicts all-cause mortality and coronary events in middle-aged individuals (the Malmo Preventive Project). Eur Heart J 2010; 31:85–91.
   PubMed Web of Science ®Google Scholar
• Hiitola P, Enlund H, Kettunen R, Sulkava R, Hartikainen S. Postural changes in blood pressure and the prevalence of orthostatic hypotension among home-dwelling elderly aged 75 years or older. J Hum Hypertens 2009; 23(1):33–39.
   PubMed Web of Science ®Google Scholar
• Baragou S, Pio M, Pessinaba S, Redah D. Prevalence of orthostatic hypotension and its risk factors in treated hypertensive black Africans. Pan Afr Med J 2012; 11:12.
   PubMedGoogle Scholar
• Pickering TG, Hall JE, Appel LJ. Recommendations of blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. A statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005; 111:697–716.
   PubMed Web of Science ®Google Scholar
• Hirsch S. A different approach to resistant hypertension. Cleve Clin J Med 2007; 74(6):449–456.
   PubMed Web of Science ®Google Scholar
• Brown MA, Buddle ML, Martin A. Is resistant hypertension really resistant? Am J Hypertens 2001; 14:1263–1269.
   PubMed Web of Science ®Google Scholar
• de la Sierra A, Segura J, Banegas JR. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57:898–902.
   PubMed Web of Science ®Google Scholar
• Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF. Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit 2003; 8:181–185.
   PubMedGoogle Scholar
• Ohkubo T, Imai Y, Tsuji I. Home blood pressure measurement has a stronger predictive power for mortality than does screening blood pressure measurement: a population-based observation in Ohasama, Japan. J Hypertens 1998; 16:971–975.
   PubMed Web of Science ®Google Scholar
• Niiranen TJ, Hänninen MR, Johansson J, Reunanen A, Jula AM. Home-measured blood pressure is a stronger predictor of cardiovascular risk than office blood pressure: the Finn-Home Study. Hypertension 2010; 55:1346–1351.
   PubMed Web of Science ®Google Scholar
• Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D. Call to action on use and reimbursement for home blood pressure monitoring: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension 2008; 52(1):10–29.
   PubMed Web of Science ®Google Scholar
• Nasothimiou EG, Tzamouranis D, Roussias LG, Stergiou GS. Home versus ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension. J Hum Hypertens, 2011. doi:10.1038/jhh.2011.98. [Epub ahead of print]
   Google Scholar
• Marui FR, Nogueira Bombig MT, Francisco YA. Assessment of resistant hypertension with home blood pressure monitoring. Arq Bras Cardiol 2010; 95(4):536–540.
   PubMed Web of Science ®Google Scholar
• Oikawa T, Obara T, Ohkubo T. Characteristics of resistant hypertension determined by self-measured blood pressure at home and office blood pressure measurements: the J-HOME study. J Hypertens 2006; 24(9):1737–1743.
   PubMed Web of Science ®Google Scholar